ABBV+11.60%33.3%
CRBP-51.42%33.3%
SKYE-99.45%33.3%
As of Oct 2, 2026, 9:55 PM ET
GLP-1 Long '24: Pharma Constituents
AbbVie Inc.ABBV | 33.3% | 1.07% | -0.46% | 0.87% | 1.57% | 15.54% | 13.75% | 28.66% | 11.60% | 36.83% | 175.80% | $464.35B |
Corbus Pharmaceuticals Holdings, Inc.CRBP | 33.3% | -3.31% | -19.75% | -44.95% | -0.32% | -22.36% | -26.25% | 21.54% | -51.42% | -69.21% | -79.97% | $113.6M |
Skye Bioscience, Inc.SKYE | 33.3% | 5.00% | -7.00% | -13.57% | -0.61% | -73.50% | -73.32% | -86.10% | -99.45% | -53.07% | -93.28% | $7.4M |
| Theme return | — | 0.92% | -9.07% | -18.98% | 0.95% | -45.40% | -49.62% | -36.47% | -75.91% | -67.08% | -61.63% | — |
| Average | 33.3% | 0.92% | -9.07% | -19.22% | 0.21% | -26.77% | -28.61% | -11.97% | -46.42% | -28.48% | 0.85% | $154.82B |
| Median | 33.3% | 1.07% | -7.00% | -13.57% | -0.32% | -22.36% | -26.25% | 21.54% | -51.42% | -53.07% | -79.97% | $113.6M |
| Std Dev | 0.0% | 3.39% | 8.01% | 19.13% | 0.97% | 36.48% | 35.59% | 52.50% | 45.47% | 46.65% | 123.83% | $218.87B |
| Min | 33.3% | -3.31% | -19.75% | -44.95% | -0.61% | -73.50% | -73.32% | -86.10% | -99.45% | -69.21% | -93.28% | $7.4M |
| Max | 33.3% | 5.00% | -0.46% | 0.87% | 1.57% | 15.54% | 13.75% | 28.66% | 11.60% | 36.83% | 175.80% | $464.35B |
| % Positive Tickers | 66.67% | 0.00% | 33.33% | 33.33% | 33.33% | 33.33% | 66.67% | 33.33% | 33.33% | 33.33% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort